Trial Profile
High-Dose Ribavirin in Combination With Standard Dose Peginterferon for Treatment of Chronic Hepatitis C Patients Who Are Nonresponders to Previous Standard Dosed Peginterferon/Ribavirin Combination Therapy.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Epoetin beta; Peginterferon alfa-2a
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2011 New trial record